Hypercoagulability and thrombosis.
This article has stressed the common hereditary and acquired blood protein defects associated with thrombosis. The commonest hereditary defects appear to be antithrombin, protein C, and protein S deficiency, and the commonest acquired defects are anticardiolipin antibodies and the lupus anticoagulant. Therefore these are the defects that should first be looked for in an individual with unexplained thrombosis. If these commoner defects are not found, the rarer defects, including HC-II, plasminogen or t-PA deficiency, dysfibrinogenemia, or elevated PAI-1, should next be sought. The incidence of activated protein C cofactor deficiency is not yet clear but may also represent a common defect. Likewise, PAI-1 defects may, with time, be shown to be quite common. The importance of finding these defects has significant implications for therapy of the individual patient and for institution of family studies to identify, inform, and possibly treat others at risk. It is expected that as knowledge of hemostasis expands, more hereditary and acquired defects, such as elevated lipoprotein (a) or defects of extrinsic (tissue factor) pathway inhibitor may be associated with enhanced risks of thrombosis.
Bick
R L
RL
Department of Oncology and Hematology, Presbyterian Hospital of Dallas, Texas.
D000991:Antithrombins / Q000172:deficiency; D001798:Blood Proteins / Q000172:deficiency; D005342:Fibrinolysis; D006801:Humans; D013923:Thromboembolism / Q000097:blood / Q000209:etiology*; D013927:Thrombosis / Q000097:blood / Q000209:etiology*
D000991:Antithrombins; D001798:Blood Proteins